Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center

Inflammatory Bowel Diseases

Volumn 16, Issue 5, 2010, Pages 830-835

  Lazarev, Mark ^a   Uliman, Thomas ^b   Schraut, Wolfgang H ^c   Kip, Kevin E ^d   Saul, Melissa ^c   Regueiro, Miguel ^c,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e Mezzanine Level   (United States)

Author keywords

Anti tumor necrosis factor; Crohn's disease; Small bowel resection

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BALSALAZIDE; BUDESONIDE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; OLSALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CROHN DISEASE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SMALL INTESTINE RESECTION; TERTIARY HEALTH CARE; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; MALE; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950654921     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21118     Document Type: Article

References (19)

1. 1. Bennell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000;231:38-45. (Pubitemid 30043937)
2. Michelassi F, Balestracci T, Chappel R, et al. Primary and recurrent Crohn's disease: experience with 1379 patients. Ann Surg. 1991;214: 230-240.
3. 3. Cosnes J, Nion-Larniurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal, surgery. Gut. 2005;54:237-241. (Pubitemid 40139240)
4. 4. Bewtra M, Su C, Lewis J. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2007;5:597-601. (Pubitemid 46660771)
5. Vernier-Massouille G, Balde M, Salieron J, et al. Natural history of Crohn's disease: a population-based cohort study. Gastroenterology. 2008;135:1106-1113.
6. 6. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549. (Pubitemid 34621118)
7. 7. Colombel JF, Sandborn WJ, Rutgeeits P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007;132:52-65. (Pubitemid 46108762)
8. 8. Rutgeeits P, Feagan BG, Lichtenstein GR, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology. 2004;126:402-413. (Pubitemid 38182297)
9. Feagan BG, Panaccione R, Sandborn WJ, et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology. 2008;135: 1493-1499.
10. Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut. 2009;58:492-500.
11. Yount RJ, Vries JK, Councill CD. The Medical Archival Retrieval System; an information retrieval system based on distributed parallel processing. Info Process Manage. 1991;27:1-11.
12. 12. Satsangi J, Silverberg MS, Vermeire S, et al, The Montreal classification of inflammatory bowel disease; controversies, consensus, and implications. Gut. 2006;55:749-753. (Pubitemid 43764536)
13. Preacher KJ. Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software]. Available from http://www.quantpsy.org.
14. 14. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-250. (Pubitemid 34784976)
15. Beaulieu DB, Mulcaire-Jones M, Ananthakrishnan AN, et al. Increasing Crohn's disease severity over time: correlating interval to first surgery with decade of diagnosis. Gastroenterology. 2008;134: A504-A504.
16. Sachar DB, Lemmer E, Ibrahim C, et al. Recurrence patterns after first resection for stricturing or penetrating Crohn's disease. Inflamm Bowel Dis. 2009;15:1071-1075.
17. 17. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial, Gastroenterology. 2004;127: 723-729. (Pubitemid 39208405)
18. D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease; a controlled randomized trial. Gastroenterology. 2008;135: 1123-1129.
19. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology. 2009;136: 441-450.